Immunosenescence and aging in HIV

Current Opinion in HIV and AIDS

Volumn 9, Issue 4, 2014, Pages 398-404

  Tsoukas, Chris ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

cardiovascular disease and immune senescence; cytomegalovirus and expansion of memory T cells; HIV comorbidities and accelerated aging; immune risk phenotype; immune senescence and immune remodelling

Indexed keywords

AGING; AUTOIMMUNE DISEASE; CELL AGING; CHRONIC INFLAMMATION; COMORBIDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSENESCENCE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; T LYMPHOCYTE; HIV INFECTIONS; IMMUNE SYSTEM; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; COMORBIDITY; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM;

EID: 84902294112     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000077     Document Type: Review

References (99)

1. Vila-Corcoles A, Ochoa-Gondar O. Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice. Drugs Aging 2013; 30:263-276.
2. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nature Immunol 2013; 14:428-436.
3. Falci C, Gianesin K, Sergi G, et al. Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol 2013; 48:1436-1442.
4. Bachi AL, Suguri VM, Ramos LR, et al. Increased production of autoantibodies and specific antibodies in response to influenza virus vaccination in physically active older individuals. Results Immunol 2013; 3:10-16.
5. Boccara F, Lang S, Meuleman C, et al. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol 2013; 61:511-523.
6. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. Br Med J 2009; 338:a3172.
7. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120-1126.
8. Aberg JA. Aging, inflammation, and HIV infection. Topics Antiviral Med 2012; 20:101-105.
9. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006; 176:2645-2653.
10. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2:659-666.
11. Sauce D, Larsen M, Fastenackels S, et al. Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest 2009; 119:3070-3078.
12. Shifrut E, Baruch K, Gal H, et al. CD4 T cell-receptor repertoire diversity is compromised in the spleen but not in the bone marrow of aged mice due to private and sporadic clonal expansions. Front Immunol 2013; 4:379.
13. Pfister G, Weiskopf D, Lazuardi L, et al. Naive T cells in the elderly: are they still there? Ann N Y Acad Sci 2006; 1067:152-157.
14. Sidler C, Woycicki R, Ilnytskyy Y, et al. Immunosenescence is associated with altered gene expression and epigenetic regulation in primary and secondary immune organs. Front Genet 2013; 4:211.
15. Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9:667-684.
16. Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010; 24:243-253.
17. Chung CP, Oeser A, Raggi P, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005; 52:3045-3053.
18. Farzaneh-Far A, Roman MJ. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Pract 2005; 59:823-824.
19. Yarur AJ, Deshpande AR, Pechman DM, et al. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011; 106:741-747.
20. Christiansen CF, Christensen S, Farkas DK, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology 2010; 35:267-274.
21. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler 2013; 19:1336-1340.
22. Christiansen CF. Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res 2012; 34:746-753.
23. Iaccarino L, Bettio S, Zen M, et al. Premature coronary heart disease in SLE: can we prevent progression? Lupus 2013; 22:1232-1242.
24. Mavroudis CA, Majumder B, Loizides S, et al. Coronary artery disease and HIV; getting to the HAART of the matter. Int J Cardiol 2013; 167:1147-1153.
25. Nikpour M, Gladman D, Urowitz M. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Lupus 2013; 22:1243-1250.
26. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349:2399-2406.
27. Olsson J, Wikby A, Johansson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121:187-201.
28. Dollard SC, Staras SA, Amin MM, et al. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 2011; 18:1895-1899.
29. Turner JE, Campbell JP, Edwards KM, et al. Rudimentary signs of immunosenescence in cytomegalovirus-seropositive healthy young adults. Age 2014; 36:287-297.
30. Cawthon RM, Smith KR, O'Brien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361:393-395.
31. Strindhall J, Skog M, Ernerudh J, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 2013; 35:985-991.
32. Chidrawar S, Khan N, Wei W, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009; 155:423-432.
33. Derhovanessian E, Maier AB, Beck R, et al. Hallmark features of immunosenescence are absent in familial longevity. J Immunol 2010; 185:4618-4624.
34. Roberts ET, Haan MN, Dowd JB, Aiello AE. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010; 172:363-371.
35. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874.
36. Gredmark-Russ S, Dzabic M, Rahbar A, et al. Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm. J Molec Med 2009; 87:347-356.
37. Haarala A, Kahonen M, Lehtimaki T, et al. Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 2012; 167:309-316.
38. Ji YN, An L, Zhan P, Chen XH. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol Biol Rep 2012; 39:6537-6546.
39. Sacre K, Hunt PW, Hsue PY, et al. A role for cytomegalovirus-specific CD4CX3CR1 T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. AIDS 2012; 26:805-814.
40. Seckert CK, Griessl M, Buttner JK, et al. Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection. Med Microbiol Immunol 2012; 201:551-566.
41. Miyazaki Y, Iwabuchi K, Kikuchi S, et al. Expansion of CD4CD28 T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis. Mult Scler 2008; 14:1044-1055.
42. Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003; 33:506-512.
43. Bonnet D, Aggoun Y, Szezepanski I, et al. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004; 18:1037-1041.
44. Parrinello CM, Sinclair E, Landay AL, et al. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIVinfected women. J Infect Dis 2012; 205:1788-1796.
45. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011; 203:452-463.
46. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis 2011; 217:207-213.
47. Sundqvist E, Bergstrom T, Daialhosein H, et al. Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Mult Scler 2014; 20:165-173.
48. Giubilato S, Liuzzo G, Brugaletta S, et al. Expansion of CD4CD28null Tlymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J 2011; 32:1214-1226.
49. Moro F, Morciano A, Tropea A, et al. CD4CD28null T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes. Fertil Steril 2012; 98:1609-1615.
50. Pawlik A, Ostanek L, Brzosko I, et al. The expansion of CD4CD28-T cells in patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5:R210-213.
51. Scarsi M, Ziglioli T, Airo P. Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis. J Rheumatol 2011; 38:2105-2111.
52. McMahon M, Hahn BH. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association. Curr Opin Immunol 2007; 19:633-639.
53. Lovett-Racke AE, Trotter JL, Lauber J, et al. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest 1998; 101:725-730.
54. Thewissen M, Somers V, Venken K, et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol 2007; 123:209-218.
55. Yokoyama Y, Fukunaga K, Ikeuchi H, et al. The CD4CD28null and the regulatory CD4CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy. Cytokine 2011; 56:466-470.
56. Bateman EA, Ayers L, Sadler R, et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012; 170:202-211.
57. Liuzzo G, Biasucci LM, Trotta G, et al. Unusual CD4CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007; 50:1450-1458.
58. Brugaletta S, Biasucci LM, Pinnelli M, et al. Novel anti-inflammatory effect of statins: reduction of CD4CD28null T lymphocyte frequency in patients with unstable angina. Heart (British Cardiac Society) 2006; 92:249-250.
59. Weyand CM, Brandes JC, Schmidt D, et al. Functional properties of CD4 CD28-T cells in the aging immune system. Mech Ageing Dev 1998; 102:131-147.
60. Zal B, Kaski JC, Arno G, et al. Heat-shock protein 60-reactive CD4CD28null T cells in patients with acute coronary syndromes. Circulation 2004; 109:1230-1235.
61. Nakajima T, Schulte S, Warrington KJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105:570-575.
62. Namekawa T, Snyder MR, Yen JH, et al. Killer cell activating receptors function as costimulatory molecules on CD4CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000; 165:1138-1145.
63. Sawai H, Park YW, Roberson J, et al. T cell costimulation by fractalkineexpressing synoviocytes in rheumatoid arthritis. Arthritis Rheum 2005; 52:1392-1401.
64. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4,CD28 T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001; 44:13-20.
65. Snyder MR, Muegge LO, Offord C, et al. Formation of the killer Ig-like receptor repertoire onCD4CD28null T cells. J Immunol 2002; 168:3839-3846.
66. Vallejo AN, Mugge LO, Klimiuk PA, et al. Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol 2000; 164:2947-2954.
67. Morishita Y, Sao H, Hansen JA, Martin PJ. A distinct subset of human CD4 cells with a limited alloreactive T cell receptor repertoire. J Immunol 1989; 143:2783-2789.
68. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Molec Med 2004; 10:119-124.
69. Walsh K, Smith RC, Kim HS. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circulation Res 2000; 87:184-188.
70. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
71. El-Sadr WM, Lundgren J, Neaton JD, et al., Strategies for Management of Antiretroviral Therapy Study Group. CD4 count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355:2283-2296.
72. Arnberg K, Larnkjaer A, Michaelsen KF, Molgaard C. Central adiposity and protein intake are associated with arterial stiffness in overweight children. J Nutr 2012; 142:878-885.
73. Ferket BS, van Kempen BJ, Hunink MG, et al. Predictive value of updating framingham risk scores with novel risk markers in the U. S. general population. PloS One 2014; 9:e88312.
74. Jonasson L, Holm J, Skalli O, et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6:131-138.
75. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21:1876-1890.
76. Dumitriu IE, Araguas ET, Baboonian C, Kaski JC. CD4 CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res 2009; 81:11-19.
77. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.
78. Mandrup-Poulsen T. IAPP boosts islet macrophage IL-1 in type 2 diabetes. Nature Immunol 2010; 11:881-883.
79. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
80. Hansson GK. Atherosclerosis: an immune disease: The Anitschkov Lecture 2007. Atherosclerosis 2009; 202:2-10.
81. Lowenstein C. Inflammation and cardiac diseases. N Engl J Med 2004; 350:1474-1475.
82. Ward JR, Wilson HL, Francis SE, et al. Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease. Clin Exp Immunol 2009; 156:386-394.
83. Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol 2010; 134:33-46.
84. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464:1357-1361.
85. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105:1158-1161.
86. Tabib A, Leroux C, Mornex JF, Loire R. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus- positive patients. Coron Artery Dis 2000; 11:41-46.
87. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135:169-175.
88. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64:5-15.
89. Edfeldt K, Bennet AM, Eriksson P, et al. Association of hypo-responsive tolllike receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004; 25:1447-1453.
90. Frostegard J, Nilsson J, Haegerstrand A, et al. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A 1990; 87:904-908.
91. Frostegard J, Wu R, Giscombe R, et al. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992; 12:461-467.
92. Xu Q, Kleindienst R, Waitz W, et al. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65 J Clin Invest 1993; 91:2693-2702.
93. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006; 26:2421-2432.
94. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25:297-336.
95. Olofsson PS, Soderstrom LA, Wagsater D, et al. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 2008; 117:1292-1301.
96. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998; 32 Suppl 3:S62-66.
97. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999; 100:96-102.
98. Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000; 84:149-161; ix.
99. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138:S419-420.